Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus	Recruiting	Not stated	2026-07-17		NCT07272837

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Alberta	249

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Mazankowski Alberta Heart Institute	Edmonton	Canada	2

Clinical trials